ROZANOLIXIZUMAB IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: RANDOMIZED SUBJECT-/INVESTIGATOR-BLIND PLACEBO-CONTROLLED PHASE 2A TRIAL
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM（2022）
关键词
CIDP, rozanolixizumab, clinical trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要